Investors & Media

VYNE Therapeutics™ is a biopharmaceutical company.

Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.

NASDAQ-GS: VYNE

2.57

Mar. 23, 2023 10:17:22
  • Change 0.04 (1.581%)
  • Volume 2,204
  • Today's Open 2.6
  • Previous Close 2.53
  • Today's High 2.6
  • Today's Low 2.57
  • 52 Week High 14.22
  • 52 Week Low 1.998